DD272998A5 - Verfahren zur herstellung von neuen arzneimitteln mit modifizierter wirkstoffabgabe in form von kuegelchen - Google Patents

Verfahren zur herstellung von neuen arzneimitteln mit modifizierter wirkstoffabgabe in form von kuegelchen Download PDF

Info

Publication number
DD272998A5
DD272998A5 DD88319283A DD31928388A DD272998A5 DD 272998 A5 DD272998 A5 DD 272998A5 DD 88319283 A DD88319283 A DD 88319283A DD 31928388 A DD31928388 A DD 31928388A DD 272998 A5 DD272998 A5 DD 272998A5
Authority
DD
German Democratic Republic
Prior art keywords
beads
drug
acid
captopril
ace inhibitor
Prior art date
Application number
DD88319283A
Other languages
German (de)
English (en)
Inventor
Yatindra M Joshi
William R Bachmann
Nemichand B Jain
Original Assignee
E. R. Squibb U. Sons,Inc.,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E. R. Squibb U. Sons,Inc.,Us filed Critical E. R. Squibb U. Sons,Inc.,Us
Publication of DD272998A5 publication Critical patent/DD272998A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD88319283A 1987-04-28 1988-08-29 Verfahren zur herstellung von neuen arzneimitteln mit modifizierter wirkstoffabgabe in form von kuegelchen DD272998A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4358487A 1987-04-28 1987-04-28

Publications (1)

Publication Number Publication Date
DD272998A5 true DD272998A5 (de) 1989-11-01

Family

ID=21927917

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88319283A DD272998A5 (de) 1987-04-28 1988-08-29 Verfahren zur herstellung von neuen arzneimitteln mit modifizierter wirkstoffabgabe in form von kuegelchen

Country Status (11)

Country Link
EP (1) EP0288732A3 (da)
JP (1) JPS63284123A (da)
KR (1) KR960006060B1 (da)
AU (1) AU613898B2 (da)
CA (1) CA1323833C (da)
DD (1) DD272998A5 (da)
DK (1) DK230288A (da)
HU (1) HU204694B (da)
NZ (1) NZ223713A (da)
PH (1) PH26689A (da)
ZA (1) ZA881488B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
DE4109134A1 (de) * 1991-03-20 1992-09-24 Knoll Ag Erzeugnisse, enthaltend verapamil und trandolapril
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
DE69231499T2 (de) * 1991-12-30 2001-05-03 Fmc Corp Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen
DE69311394T2 (de) * 1992-02-20 1997-10-30 Euro Celtique Sa Arzneimittel verzögerter Wirkstoffabgabe
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
WO2000022909A2 (en) * 1998-10-19 2000-04-27 Biotech Australia Pty. Limited Systems for oral delivery
GB2374874A (en) * 2001-04-11 2002-10-30 Bioprogress Tech Int Inc Modified cellulose films
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
WO2003094899A1 (es) * 2002-05-09 2003-11-20 Diffucap-Chemobras Química E Farmacéutica, Ltda. Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
RU2382637C2 (ru) * 2004-04-30 2010-02-27 Астеллас Фарма Инк. Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217347A (en) * 1977-12-27 1980-08-12 E. R. Squibb & Sons, Inc. Method of treating hypertension and medicaments therefor
NZ196349A (en) * 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
JPS60262919A (ja) * 1984-06-11 1985-12-26 Kawasaki Steel Corp 一方向性珪素鋼のスラブ加熱方法
JPS61125687A (ja) * 1984-11-22 1986-06-13 Hitachi Ltd パタ−ン抽出方式
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0617254B2 (ja) * 1986-05-28 1994-03-09 日産化学工業株式会社 硬化コンクリ−トの劣化防止方法

Also Published As

Publication number Publication date
ZA881488B (en) 1988-08-22
JPS63284123A (ja) 1988-11-21
DK230288D0 (da) 1988-04-27
EP0288732A3 (en) 1990-11-07
KR960006060B1 (ko) 1996-05-08
CA1323833C (en) 1993-11-02
NZ223713A (en) 1990-06-26
DK230288A (da) 1988-10-29
KR880012215A (ko) 1988-11-26
HU204694B (en) 1992-02-28
AU613898B2 (en) 1991-08-15
HUT52944A (en) 1990-09-28
AU1283588A (en) 1988-11-03
PH26689A (en) 1992-09-15
EP0288732A2 (en) 1988-11-02

Similar Documents

Publication Publication Date Title
US4808413A (en) Pharmaceutical compositions in the form of beadlets and method
DD272998A5 (de) Verfahren zur herstellung von neuen arzneimitteln mit modifizierter wirkstoffabgabe in form von kuegelchen
US5049394A (en) Pharmaceutical composition containing high drug load and method for preparing same
EP0925060B1 (de) Schnellzerfallende pellets
DE60020551T2 (de) Orale formulierung zur verabreichung in den ileum enthaltend einen hemmstoff des ileum-gallensäuretransports
US4404183A (en) Sustained release pharmaceutical composition of solid medical material
US4765990A (en) Sustained-release nifedipine preparation
DE69819205T2 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
DE69721845T2 (de) Orale morphinzubereitung in teilchenform
DE69924710T2 (de) Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie
EP0934058B1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
DD273197A5 (de) Verfahren zur herstellung eines omeprazol enthaltenden oralen pharmazeutischen praeparates
EP1113787B1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
DE4332394A1 (de) Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
DD260222B5 (de) Verfahren zur Herstellung eines oralen pharmazeutischen Praeparates das eine saeureunbestaendige Verbindung enthaelt
DE3856555T2 (de) Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption
EP0339420B1 (de) DHP-Retard-Zubereitung
DE19901692A1 (de) Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
EP0306699A1 (de) Dihydropyridin-Retard-Zubereitung
EP1017392B1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
EP0378137A2 (de) Neue Arzneiform
DE60308828T2 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung
CA1334074C (en) Pharmaceutical composition containing high drug load and method for preparing same
EP0116358B1 (de) Komplexe von Prostaglandinen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee